Salud Pública y Materno-Infantil
Departamento
University of Manitoba
Winnipeg, CanadáPublicaciones en colaboración con investigadores/as de University of Manitoba (5)
2023
2021
-
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
Cardiovascular Diabetology, Vol. 20, Núm. 1
2020
-
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 7, pp. 606-615
2018
-
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Journal of the American College of Cardiology, Vol. 71, Núm. 23, pp. 2628-2639
-
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48